NCT06797479View on ClinicalTrials.gov

Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 1, 2030

Study Completion Date

December 1, 2030

Conditions

Gynecological CancerImmunotherapy

Interventions

PROCEDURE

Blood samples for the analysis of sildenafil in plasma

To detect the ICI mAbs in patients' blood plasma samples, we select three anti PD-1 mAbs (cemiplimab, dostarlimab and pembrolizumab) as prognostic biomarkers which will be quantified using different biochemical/analytical assays.

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER